|
| | |
|
|
|
Newsletters |
Your Gateway to a Fast
Changing World
Product News Alerts |
 |
Receive similar stories and other customized
news to keep you in the know on the products shaping
industry. |
Subscribe Free Today
Subscribe View
Sample |
Industry
Market Trends
Has Got It |
- Latest developments
- Trends
- Best practices
- Opinions & Commentary
|
 |
Get Ahead.
Get IMT.
Subscribe Free Today
Subscribe View
Sample |
|
|
|
Cardiac Science Inc.
BOTHELL, Wash., March 12 -- Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will present at the Washington Biotechnology and Biomedical Association (WBBA) 2008 Invest Northwest CEO and Investor Forum at the Bell Harbor International Conference Center in Seattle. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results, during the Company's presentation on Tuesday, March 18 at 11:30 a.m. local time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com/. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com/ for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit www.cardiacscience.com.
Company Contact: Mike Matysik Cardiac Science Corporation Sr. Vice President and CFO (425) 402-2009
Investor Contact: Jenifer Kirtland EVC Group, Inc. (415) 896-6820 jkirtland@evcgroup.com
Media Contact: Christopher Gale EVC Group, Inc. (201) 646-5431 (203) 570-4681 cgale@evcgroup.com
Source: Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
Contacts:
|
del.icio.us
DIGG
Facebook
Reddit
StumbleUpon
Twitter
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
